Login to Your Account



Washington Roundup

Federal Circuit Broadens Hatch-Waxman Safe Harbor

By Mari Serebrov
Washington Editor

Tuesday, August 7, 2012
WASHINGTON – In vacating a preliminary injunction that protected Momenta Pharmaceuticals Inc.'s $1 billion a year monopoly on generic Lovenox, the Federal Circuit gave the makers of generic drugs a much wider safe harbor under Hatch-Waxman.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription